Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Contemporary Brachytherapy|April 26, 2021
Regression of posterior uveal melanoma following iodine-125 plaque radiotherapy based on pre-treatment tumor apical heightDavid Miguel, María Antonia Saornil, Jesús María de Frutos, et al.
GMS Ophthalmology Cases|December 19, 2023
Focal reactive nodular gliosis: an extremely rare retinal astrocytic tumorSaúl Villoria-Díaz, María Antonia Saornil-Álvarez, Ciro García-Álvarez, et al.
Arquivos Brasileiros De Oftalmologia|May 11, 2022
BRAF and NRAS prognostic values in conjunctival melanoma: analysis and literature reviewFrancisco Javier Valentín-Bravo, Álvaro Pérez-Rodríguez, Ciro García-Álvarez, et al.
European Journal of Ophthalmology|April 15, 2025
Retrospective analysis of complications in enucleated patients with porous polyethylene implants for uveal melanomaIgnacio López Miñarro, Ciro García Álvarez, María Fe Muñoz Moreno, et al.
Journal of Contemporary Brachytherapy|January 30, 2014
Bilateral episcleral brachytherapy in simultaneous choroidal melanoma and circumscribed hemangiomaMaría Encarnación Correa-Pérez, María Antonia Saornil, Ciro García-Álvarez, et al.
Cancers|August 10, 2024
Long Term Follow-Up Observation in Small Choroidal Melanocytic TumorsLaura Prieto-Domínguez, Ciro García-Álvarez, Maria F Muñoz-Moreno, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 4, 2012
Episcleral brachytherapy for uveal melanoma: analysis of 136 casesCiro García-Álvarez, María Antonia Saornil, Francisco López-Lara, et al.
Journal of Contemporary Brachytherapy|September 22, 2018
Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part IIDavid Miguel, Jesús María de Frutos-Baraja, Francisco López-Lara, et al.
Journal of Contemporary Brachytherapy|September 22, 2018
Radiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part IDavid Miguel, Jesús María de Frutos-Baraja, Francisco López-Lara, et al.
International Journal of Ophthalmology|December 28, 2018
Episcleral brachytherapy as an effective alternative in vasoproliferative tumorsMarta Para Prieto, Maria Antonia Saornil, Jesús María de Frutos Baraja, et al.
Pageof 2